TGF-β is a well-known soluble factor that attenuates the anti-tumor response by inhibiting the activation of dendritic cells (DCs) [21] and polarizing macrophages towards the M2 phenotype [22], as well as inducing Treg cell activation [23]. Here, TGFB1 is linked to neoplasm.